CompletedInterventionalNot ApplicableLast updated Jan 11, 2023

Local and General Immune Response After Coronavirus Disease (COVID-19) Vaccination in Volunteers

COVACC2: Local and General Immune Response After COVID-19 Vaccination in Volunteers

Overview

ClinicalTrials.gov ID: NCT04996238
Lead Sponsor: University Hospital, GhentOTHER
Brief Summary: This study aims to gain more insight in the immunological characteristics and immune response on a local level (the nose) and systemic level (the blood) of healthy people vaccinated with the current available COVID-19 messenger ribonucleic acid (mRNA; BNT162b2) and viral vector based (ChAdOx1) vaccines.
Study Type

Status

Study Record Dates

NCT06851611Completed

The Safety and Antibody Response of the Nasal COV2 Vaccine Against the SARS-CoV-2 Virus

NCT04842305Unknown status

Mucosal Immunity in Terms of SARS-CoV-2 Antibodies in Saliva After COVID-19 Infection and Vaccination

NCT05379478Completed

Immune Responses to COVID-19 Infection or Vaccination

NCT04944134Completed

COVID-19 Antibody Levels After Vaccines

NCT04706390Recruiting

Comparison of the Immune Response to Natural COVID-19 Infection and Vaccination

NCT04431414Completed

A Study of Immune Responses to the Virus That Causes COVID-19